Table 2 Tumor inhibition rate in the CP70 group and A2780 group
From: Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells
Group | Tumor-inhibition rate | P-value | |
|---|---|---|---|
CP70 | CP70 + DDP group | 28.73% | < 0.05a |
CP70 + DDP + Metformin group | 83.93% | ||
A2780 | A2780 + DDP group | 59.16% | < 0.05b |
A2780 + DDP + Metformin group | 79.03% | ||